Skip to main content
. Author manuscript; available in PMC: 2017 Jul 13.
Published in final edited form as: Circ Res. 2016 Jun 10;118(12):1858–1860. doi: 10.1161/CIRCRESAHA.116.308978

Figure. Summary of predicted pathophysiology leading to atherosclerotic vascular diseases that can account as the potential unifying factor in the clinical associations noted with long-term proton pump inhibitor (PPI) use.

Figure

It is important to note the limitation that there are gaps in translating conclusions from observations noted in one type of endothelial cells (EC) in culture to in vivo vascular dysfunction. NO indicates nitric oxide.